Medicare limits coverage of controversial Alzheimer's drug to those in clinical trials

4 years ago 19

Medicare will restrict coverage of the controversial and costly Alzheimer's drug Aduhelm to those enrolled in qualifying clinical trials, the Centers for Medicare and Medicaid Services announced Thursday.

1. Homepage
2. National News
3. Medicare limits coverage of controversial Alzheimer's drug to those in clinical trials